Study Stopped
sponsor decision
Assessing Continuous Non- Invasive Blood Glucose Sensor- Physical Logic AG
1 other identifier
interventional
4
1 country
1
Brief Summary
The present study is aimed to evaluate the feasibility of a new noninvasive method to measure continuous glucose values using electromagnetic radiation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2010
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 21, 2010
CompletedFirst Posted
Study publicly available on registry
November 24, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2011
CompletedNovember 20, 2012
November 1, 2012
3 months
November 21, 2010
November 18, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation between continuous glucose measurements using study device and YSI(yellow springs instrument)
Correlation between continuous glucose measurements using study device (Physical Logic) and YSI(yellow springs instrument)at variable glucose levels
up to 24 weeks
Study Arms (1)
Study group
EXPERIMENTALPatients will be monitored to assess continuous blood glucose levels using the study device (Physical Logic) and reference methods, during 2-3 clinic visits, lasting 6-8 hours each
Interventions
Patients will be monitored to assess continuous blood glucose levels using the study device (Physical Logic) and reference methods, during 2-3 clinic visits, lasting 6-8 hours each
Eligibility Criteria
You may qualify if:
- Signing an inform consent form
- Age \> 18 years old
- Willing to perform all study related procedures
You may not qualify if:
- Known or suspected allergy to the sensor or one of its components
- Psychiatric disorder
- Patients with one or more of the following diseases: malignancy, myocardial insufficiency, nephrologic disease or any other chronic disease
- Patients who are not willing or are not capable of performing the protocol requirements
- Participating in another study that includes investigational drug or investigational equipment
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Schneider Children's Medical center
Petah Tikva, 49202, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Revital Nimri, Dr
Schenider Children's Medical
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 21, 2010
First Posted
November 24, 2010
Study Start
November 1, 2010
Primary Completion
February 1, 2011
Study Completion
February 1, 2011
Last Updated
November 20, 2012
Record last verified: 2012-11